cerrar
Tagged with switzerland

Interview: Natascha Schill – Managing Director, Biogen…
MD Natascha Schill discusses the growing importance and commitment that Biogen has to Switzerland, including a USD one billion investment in new…

Interview: Pascal Strupler – Director General, Federal…
Pascal Strupler of the Federal Office of Public Health discusses the intricacies of the Swiss healthcare system, highlighting the importance of the…

Interview: Olaf Weppner – General Manager, AbbVie…
Olaf Weppner, General Manager of AbbVie Switzerland, highlights AbbVie’s intended foray into oncology, the importance of immunology to the group,…

Interview: Dr. Catherine Chammartin – Director General,…
Dr. Catherine Chammartin of the Swiss Federal Institute of Intellectual Property (IPI) describes the strong elements of an IP system and its…

Interview: Tuomo Pätsi – President EMEA, Celgene,…
Tuomo Pätsi, President of the EMEA region for Celgene, talks about marking the tenth anniversary of Switzerland as Celgene´s EMEA headquarters;…

Interview: Prof. Dr. med. Adriano Aguzzi – Director,…
Prof. Dr. med. Adriano Aguzzi provides insight on the past, present, and future of prion and antibody therapy research in Switzerland. The Institute…

Interview: Prof. Jürg Utzinger – Director, Swiss Tropical…
Professor Jürg Utzinger of the Swiss Tropical and Public Health Institute (Swiss TPH) emphasizes the importance of partnerships and sharing…

Interview: Ludo Ooms – Managing Director…
Janssen Switzerland’s Ludo Ooms highlights the strengths of the Swiss healthcare and life sciences sector including the efficiency of the…

Interview: Professor Dr. Susan M. Gasser – Director,…
Professor Dr. Susan M. Gasser of the Friedrich Miescher Institute for Biomedical Research describes FMI’s fundamental connection between academia…

Interview: Pamela Alexa – Country Manager, Pfizer…
Pfizer Switzerland’s Pamela Alexa discusses launching Xeljanz (tofacitinib), a treatment for adult patients with moderate to severe active…

Swiss Pharma’s New Entrepreneurial Mind-Set
Switzerland’s pharma industry is moving beyond staid conservatism and embracing risk in order to compete internationally and foster a new culture of…

Interview: Daniela Suter – CEO, Gen Suisse, Switzerland
In the year of Gen Suisse’s 25th anniversary, CEO Daniela Suter talks supporting dialogue between scientists and politicians on life sciences in…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here